Petter Slyngstadli

Part of Norne Eierselskap AS, Norne Securities AS is a securities company based in Vilnius, Lithuania. Tomas Skeivys has been the CEO of the company since 2021. The Lithuanian company is the largest market maker in shares on the Oslo Stock Exchange and provides financial advisory services for all types of financial transactions. The company has extensive industry knowledge in fisheries, industry, infrastructure, energy, and tourism. Norne Securities also offers debt management, portfolio management, property financing, and green financing. The company works closely with its owners, 14 independent savings banks.

Nordea Investment Management AB (Norway) (NIM Norway) is the investment management division of Nordea Investment Management AB, itself a subsidiary of financial group Nordea Bank AB (SSE: NDA, ADR: NRBAY) in Norway. Headquartered in Bergen, NIM Norway manages a range of Norwegian funds, including pension funds, primarily for institutions.

Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.